MA42552A - Compositions pharmaceutiques de flurbiprofène et de tramadol - Google Patents
Compositions pharmaceutiques de flurbiprofène et de tramadolInfo
- Publication number
- MA42552A MA42552A MA042552A MA42552A MA42552A MA 42552 A MA42552 A MA 42552A MA 042552 A MA042552 A MA 042552A MA 42552 A MA42552 A MA 42552A MA 42552 A MA42552 A MA 42552A
- Authority
- MA
- Morocco
- Prior art keywords
- tramadol
- flurbiprofen
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201605504 | 2016-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42552A true MA42552A (fr) | 2018-06-06 |
Family
ID=58638778
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042552A MA42552A (fr) | 2016-04-28 | 2017-04-27 | Compositions pharmaceutiques de flurbiprofène et de tramadol |
MA042553A MA42553A (fr) | 2016-04-28 | 2017-04-27 | Formulations à libération prolongée de flurbiprofène et de tramadol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042553A MA42553A (fr) | 2016-04-28 | 2017-04-27 | Formulations à libération prolongée de flurbiprofène et de tramadol |
Country Status (4)
Country | Link |
---|---|
US (1) | US20170312236A1 (fr) |
EP (1) | EP3238713A1 (fr) |
MA (2) | MA42552A (fr) |
TR (1) | TR201605632A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11554112B2 (en) | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
MX2021009755A (es) | 2019-02-13 | 2021-11-17 | Iterum Therapeutics International Ltd | Combinaciones de compuestos beta-lactámicos y probenecid, y usos de los mismos. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339105B1 (en) | 1999-10-12 | 2002-01-15 | Ortho-Mcneil Pharmaceutical, Inc. | Analgesic regimen |
US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
US20080031950A1 (en) * | 2007-04-27 | 2008-02-07 | Nectid Inc. | Novel anelgesic combination |
-
2016
- 2016-05-02 TR TR2016/05632A patent/TR201605632A1/tr unknown
-
2017
- 2017-04-26 US US15/498,100 patent/US20170312236A1/en not_active Abandoned
- 2017-04-27 MA MA042552A patent/MA42552A/fr unknown
- 2017-04-27 MA MA042553A patent/MA42553A/fr unknown
- 2017-04-27 EP EP17168457.4A patent/EP3238713A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MA42553A (fr) | 2018-06-06 |
US20170312236A1 (en) | 2017-11-02 |
TR201605632A1 (tr) | 2017-11-21 |
EP3238713A1 (fr) | 2017-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA46525A (fr) | Anticorps anti-lag-3 et compositions | |
MA44659A (fr) | Anticorps anti-tim-3 et compositions | |
MA46466A (fr) | Formulations pharmaceutiques de protéines à viscosité réduite | |
DK3529248T3 (da) | Farmaceutiske sammensætninger | |
MA52257A (fr) | Compositions pharmaceutiques comprenant blautia et leur administration orale | |
DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
JP2018172409A5 (ja) | 15−hepeを含む組成物および同組成物を使用する方法 | |
MA50541A (fr) | Formulations pharmaceutiques | |
MA47816A (fr) | Composition pharmaceutique comprenant du sélexipag | |
MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
MA46867A (fr) | Formulations pharmaceutiques | |
MA42303A (fr) | Formulations pharmaceutiques | |
MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
MA42196A (fr) | Particules de fumarate de diméthyle et leurs compositions pharmaceutiques | |
DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
DK3634377T3 (da) | Farmaceutisk formulering | |
MA49837A (fr) | Compositions pharmaceutiques | |
MA43705A (fr) | Formulation pharmaceutique | |
DK3288379T3 (da) | Peptidsammensætninger og anvendelsesmåder | |
MA45187A (fr) | Combinaisons pharmaceutiques | |
MA47516A (fr) | Composition pharmaceutique | |
DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
DK3129057T3 (da) | Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi | |
DK3601277T3 (da) | Farmaceutisk formulering | |
DK3503885T3 (da) | Farmaceutisk præparat og fremgangsmåder til anvendelse heraf |